Leukemia, Myelogenous, Chronic, BCR-ABL PositiveBone MarrowBone Marrow CellsLeukemia, MyeloidBenzamidesBone Marrow TransplantationFusion Proteins, bcr-ablLeukemia, Myeloid, AcutePiperazinesPyrimidinesLeukemiaLeukemia, Myeloid, Chronic-PhaseBone and BonesBlast CrisisGenes, ablGene Expression Regulation, LeukemicHematopoietic Stem CellsPhiladelphia ChromosomeLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeAntineoplastic AgentsCytogenetic AnalysisProtein Kinase InhibitorsLeukemia, Myeloid, Accelerated PhaseK562 CellsTransplantation, HomologousBone Marrow ExaminationBone Marrow DiseasesRemission InductionThiazolesBone RemodelingPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug Resistance, NeoplasmLeukemia, Lymphocytic, Chronic, B-CellCytarabineLeukemia, LymphoidBone Marrow NeoplasmsAcute DiseaseTreatment OutcomeAntigens, CD34Leukemia, ExperimentalHematopoiesisMyelodysplastic SyndromesNeoplastic Stem CellsCell DifferentiationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationKaryotypingBone DensityHL-60 CellsCytogeneticsNeoplasm, ResidualColony-Forming Units Assayfms-Like Tyrosine Kinase 3Bone Marrow PurgingPrognosisFlow CytometryBone ResorptionRecurrenceGranulocytesProtein-Tyrosine KinasesChromosome AberrationsTranslocation, GeneticInterferon-alphaTime FactorsMyeloproliferative DisordersWhole-Body IrradiationSurvival AnalysisLeukemia, Monocytic, AcuteTransplantation, AutologousProto-Oncogene Proteins c-bcrDisease-Free SurvivalMice, Inbred C57BLBusulfanCells, CulturedImmunophenotypingAntineoplastic Combined Chemotherapy ProtocolsTumor Cells, CulturedDaunorubicinIn Situ Hybridization, FluorescenceReverse Transcriptase Polymerase Chain ReactionBone NeoplasmsLeukemia Virus, MurineRNA, MessengerMutationApoptosisNeoplasm ProteinsHarringtoninesSurvival RateLeukemia, Myelomonocytic, AcuteChromosomes, Human, Pair 9Cell DivisionChromosomes, Human, 21-22 and YBone DevelopmentTransplantation ConditioningRNA, NeoplasmGranulocyte Colony-Stimulating FactorPolymerase Chain ReactionTissue DonorsCore Binding Factor Alpha 2 SubunitMyeloid-Lymphoid Leukemia Protein